Birgitte Bjørnhart
5PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Aug 03, 2023
5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy.Birgitte Bjørnhart, Mette Thune Mouritzen, Charlotte Kristiansen
|Apr 12, 2022
Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis.Birgitte Bjørnhart, Karin Holmskov Hansen, Jon Thor Asmussen
|Jan 11, 2022
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.Mette T Mouritzen, Karen F Junker, Andreas Carus
|Oct 13, 2021
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy.Mette T Mouritzen, Andreas Carus, Morten Ladekarl
|May 14, 2019
Efficacy and safety of immune checkpoint inhibitors in a Danish real life non-small cell lung cancer population: a retrospective cohort study.Birgitte Bjørnhart, Karin H Hansen, Trine L Jørgensen
Pageof 1
Frequent Collaborators
3 joint publications
Mette Thune Mouritzen
3 joint publications
Charlotte Kristiansen
2 joint publications
Andreas Carus
2 joint publications
Morten Ladekarl
2 joint publications
Jacob W Larsen
2 joint publications
Jens B Sørensen
2 joint publications
Seppo W Langer
2 joint publications
Tine Schytte
1 joint publications
Anna Livbjerg
1 joint publications
Anne-Cathrine Østby
